Markets and Inflation, Shutdown Deadline Looms, FedEx Spinoff Plans, Nike’s Turnaround Push 12/20/24
Squawk on the Street
00:00
Vertex Pharmaceuticals and the Opioid Crisis: Unmet Hopes
This chapter explores the latest trial outcomes from Vertex Pharmaceuticals, contrasting management's optimistic claims with analysts' skepticism. It also highlights the broader implications of these results within the ongoing U.S. opioid crisis and the challenges posed by addiction and fentanyl.
Transcript
Play full episode
